Last Updated on April 30, 2026 by Jaspreet Kaur
A new study has found out a big reason behind mevalonate kinase deficiency, which is a rare and serious disease that causes a lot of inflammation. Mevalonate kinase deficiency is also known as MKD. The researchers found out that a specific type of cell called natural killer cells does not work properly in people with mevalonate kinase deficiency. This causes a lot of inflammation. It gives us a new idea about what causes the disease and how we can treat it.
About mevalonate kinase deficiency
Mevalonate kinase deficiency is a condition that people have in their lives. It affects both kids and adults. Even though it is rare, a lot of people might have it without knowing. People with kinase deficiency get very sick with high fevers, skin rashes, joint pain and stomach problems. Sometimes these episodes can be life-threatening. It really affects the quality of life of people with mevalonate kinase deficiency.
For a time scientists thought that another type of immune cell called macrophages was the main cause of the disease. So the treatments we have now try to stop the things that these cells do. These treatments only work for about half of the people with mevalonate kinase deficiency, which means a lot of people do not have good options.
New discovery
The new study says that natural killer cells are actually the cause of inflammation in people with mevalonate kinase deficiency. These cells help our bodies fight off viruses. Normally natural killer cells kill the cells by releasing bad things that are stored inside them.
In people with mevalonate kinase deficiency this does not work right. The bad things get stuck inside the natural killer cells so they cannot kill the cells like they should. This makes our immune system not work well.
Domino effect
When natural killer cells cannot kill the cells, they do something else. They release a lot of interferon gamma, which makes our immune system get really excited and cause a lot of inflammation all over our body.
This is what causes the symptoms that people with mevalonate kinase deficiency get, like high fevers and swollen organs. By helping our bodies our immune system gets too excited and hurts us.
Changing old views
This new study changes what we thought we knew about mevalonate kinase deficiency. For 30 years scientists thought that macrophages were the main cause of inflammation. Now we know that the real problem is with natural killer cells.
This means that we can start working on treatments that fix the real problem instead of just treating the symptoms.
Promising treatment
One of the exciting things about this study is that it might lead to new treatments. The researchers tried using a type of medicine called JAK inhibitors, which can block the things that our immune system does.
They used one of these medicines called baricitinib to treat a baby with kinase deficiency. This medicine is already used to treat conditions, like arthritis and eczema. When they gave it to the baby the baby got better. The baby had fewer episodes of inflammation.
Broader impact
This discovery might help people with these conditions too. The researchers think that some other genetic conditions might be related to mevalonate kinase deficiency and might have the problem with natural killer cells.
If this is true it could lead to diagnoses and treatments for more people.
Ending delays
A lot of people with rare diseases have to wait a long time to get a correct diagnosis. If we can understand what really causes these conditions we might be able to diagnose and treat people faster.
Future research
We need to do studies to see if these new treatments really work. We need to try them on people and see if they are safe and effective.
The researchers are also trying to figure out how natural killer cells get broken so that If we can fix them earlier in the disease.
A new direction
This study is a step forward in understanding and treating mevalonate kinase deficiency. By looking at natural killer cells of macrophages we have a better idea of what is going on.
This discovery gives us hope for treatments and shows us that we should always question what we think we know.
Conclusion
Finding out that misfiring natural killer cells cause inflammation in kinase deficiency is a big breakthrough. With treatments, on the way this discovery could change how we treat the disease in the future.
It gives people with kinase deficiency and their families hope for better treatments and a better life.